Laboratory Analytical Instruments - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Laboratory industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Laboratory Analytical Instruments - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Laboratory Analytical Instruments
Corporate Insider Buy Sell Ratio (Insider Count) - Laboratory Analytical Instruments
Laboratory Analytical Instruments - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-06-03 BNGO / Bionano Genomics, Inc. 4 Adamchak Mark F - Taxes D 3.69 -7
2025-06-03 BNGO / Bionano Genomics, Inc. 4 Holmlin R. Erik F - Taxes D 3.69 -75
2025-06-03 TXG / 10x Genomics, Inc. 4 Mateo Alan A - Award D 15,357
2025-06-03 TXG / 10x Genomics, Inc. 4 SULIMAN SHEHNAAZ A - Award D 15,357
2025-06-03 TXG / 10x Genomics, Inc. 4 Kosaraju Sridhar A - Award D 15,357
2025-06-03 TXG / 10x Genomics, Inc. 4 Teichmann Sarah A. A - Award D 15,357
2025-06-03 TXG / 10x Genomics, Inc. 4 STUELPNAGEL JOHN R A - Award D 15,357
2025-06-03 TXG / 10x Genomics, Inc. 4 Popovits Kimberly J A - Award D 15,357
2025-06-02 CTKB / Cytek Biosciences, Inc. 4 McCombe William D. P - Purchase D 2.78 35,000
2025-05-31 QTRX / Quanterix Corporation 4 Toloue Masoud F - Taxes D 5.20 -254
2025-05-30 PRPO / Precipio, Inc. 4 SANDBERG RICHARD A Wythburn Associates, Ltd, 94% owned jointly by reporting person and spouse P - Purchase I 9.44 8
2025-05-30 PRPO / Precipio, Inc. 4 SANDBERG RICHARD A Wythburn Associates, Ltd, 94% owned jointly by reporting person and spouse P - Purchase I 10.00 1,391
2025-05-30 A / Agilent Technologies, Inc. 4 Ancher-Jensen Henrik F - Taxes D 111.92 -1,755
2025-05-29 RVTY / Revvity, Inc. 4 McMurry-Heath Michelle S - Sale D 92.165 -600
2025-05-29 NAUT / Nautilus Biotechnology, Inc. 4 Mowry Anna P - Purchase D 0.7659 15,000
2025-05-29 TXG / 10x Genomics, Inc. 4 Saxonov Serge G - Gift D -3,000
2025-05-28 MTD / Mettler-Toledo International Inc. 4 Kelly Michael A S - Sale D 1159.93 -1,062
2025-05-28 MTD / Mettler-Toledo International Inc. 4 Kelly Michael A M - Exercise D 312.36 1,062
2025-05-27 PRPO / Precipio, Inc. 4 SANDBERG RICHARD A Wythburn Associates, Ltd, 94% owned jointly by reporting person and spouse P - Purchase I 9.80 101
2025-05-25 EYPT / EyePoint Pharmaceuticals, Inc. 4 Elston George M - Exercise D 7,500
2025-05-25 EYPT / EyePoint Pharmaceuticals, Inc. 4 Elston George F - Taxes D 5.68 -2,202
2025-05-23 AVTR / Avantor, Inc. 4 SUMME GREGORY L By a Trust P - Purchase I 12.50 30,000
2025-05-22 TXG / 10x Genomics, Inc. 4 Taich Adam S - Sale D 8.2993 -4,044
2025-05-22 TXG / 10x Genomics, Inc. 4 Saxonov Serge S - Sale D 8.2993 -9,343
2025-05-22 TXG / 10x Genomics, Inc. 4 Hindson Benjamin J. S - Sale D 8.2993 -7,485
2025-05-22 PRPO / Precipio, Inc. 4 SANDBERG RICHARD A Wythburn Associates, Ltd, 94% owned jointly by reporting person and spouse P - Purchase I 9.33 500
2025-05-22 AVTR / Avantor, Inc. 4 SUMME GREGORY L By a Trust P - Purchase I 12.65 20,000
2025-05-22 A / Agilent Technologies, Inc. 4 McMahon Robert W. F - Taxes D 109.68 -3,499
2025-05-22 RPID / Rapid Micro Biosystems, Inc. 4 RICCIARDI NATALE S A - Award D 14,300
2025-05-22 RPID / Rapid Micro Biosystems, Inc. 4 Malloy Kirk A - Award D 14,300
2025-05-22 ASTC / Astrotech Corporation 4 Canas Jennifer A - Award D 5,250
2025-05-22 RPID / Rapid Micro Biosystems, Inc. 4 LOWENSTEIN INESE A - Award D 14,300
2025-05-22 RPID / Rapid Micro Biosystems, Inc. 4 Kollender Richard S A - Award D 14,300
2025-05-22 RPID / Rapid Micro Biosystems, Inc. 4 PEI MELINDA LITHERLAND A - Award D 14,300
2025-05-21 PRPO / Precipio, Inc. 4 SANDBERG RICHARD A Wythburn Associates, Ltd, 94% owned jointly by reporting person and spouse P - Purchase I 9.30 3,000
2025-05-21 PRPO / Precipio, Inc. 4 SANDBERG RICHARD A Roth IRA for the benefit of Richard A Sandberg P - Purchase I 9.25 5,035
2025-05-21 AVTR / Avantor, Inc. 4 Stubblefield Michael G - Gift I 76,000
2025-05-21 AVTR / Avantor, Inc. 4 Stubblefield Michael G - Gift D -76,000
2025-05-21 A / Agilent Technologies, Inc. 4/A Soriot Pascal F - Taxes D 108.91 -504
2025-05-21 ILMN / Illumina, Inc. 4 SIEGEL SUSAN E A - Award D 3,780
2025-05-21 A / Agilent Technologies, Inc. 4 Soriot Pascal A - Award D 108.91 1,677
2025-05-21 ILMN / Illumina, Inc. 4 Gottlieb Scott A - Award D 3,780
2025-05-21 ILMN / Illumina, Inc. 4 EPSTEIN ROBERT S A - Award D 3,780
2025-05-21 ILMN / Illumina, Inc. 4 GUTHART GARY S A - Award D 3,780
2025-05-21 ILMN / Illumina, Inc. 4 SCHILLER PHILIP W A - Award D 3,780
2025-05-21 A / Agilent Technologies, Inc. 4 Brown Judy L A - Award D 108.91 1,677
2025-05-21 ILMN / Illumina, Inc. 4 Meister Keith A. A - Award D 3,780
2025-05-21 ILMN / Illumina, Inc. 4 ARNOLD FRANCES A - Award D 3,780
2025-05-21 ILMN / Illumina, Inc. 4 RICHO ANNA A - Award D 3,780
2025-05-21 A / Agilent Technologies, Inc. 4/A Brown Judy L A - Award D 108.91 1,677
P
Achat sur le marché public ou privé d'un titre non dérivé ou dérivé
S
Vente sur le marché public ou privé d'un titre non dérivé ou dérivé
A
Attribution, récompense ou autre acquisition de titres de l'entreprise (comme une option).
C
Conversion d'un produit dérivé
D
Vente ou transfert de titres à l'entreprise
F
Paiement du prix d'exercice ou de la dette fiscale en utilisant une partie des titres reçus de l'entreprise
G
Don de titres par ou à l'initié
K
Swaps d'actions et opérations de couverture similaires
M
Exercice ou conversion d'un titre dérivé reçu de l'entreprise (tel qu'une option)
V
Une transaction déclarée volontairement sur le formulaire 4
J
Autre (accompagnée d'une note de bas de page décrivant la transaction)